Advertisement

Topics

With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer

06:55 EST 14 Nov 2017 | Xconomy

Genetic engineering a patient’s own immune cells to make them better cancer fighters is the latest tool in oncology, following FDA approvals of two such therapies this year. But executives at Torque Therapeutics say cell therapy can be further improved by enlisting T cells to carry a drug payload that prompts a more targeted and […]

Original Article: With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer

NEXT ARTICLE

More From BioPortfolio on "With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Genetic Engineering
Genetic engineering is the process of manually adding new DNA to an organism. The goal is to add one or more new traits that are not already found in that organism. Examples of genetically engineered (transgenic) organisms currently on the market include...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...